Related Experiment Video
Updated: Aug 4, 2026
06:38
A Three-dimensional Model of Spheroids to Study Colon Cancer Stem Cells
Published on: January 22, 2021
[CD44 (HCAM) expression in subserous gallbladder carcinoma]
1Unidad de Anatomía Patológica y Citopatología Hospital Temuco, Departamento de Cirugía, Facultad de Medicina, Universidad de la Frontera, Temuco, Chile.
Revista Medica De Chile
|September 13, 2001
Summary
Abnormal CD44 expression is found in nearly half of subserous gallbladder carcinomas. This finding is crucial for understanding gallbladder cancer progression and patient outcomes.
Area of Science:
- Oncology
- Cell Biology
- Molecular Diagnostics
Background:
- CD44 (HCAM) is a cell adhesion molecule involved in cell interactions and tumor invasion.
- Understanding CD44's role is vital in various cancers, including gallbladder carcinoma.
Purpose of the Study:
- To investigate the significance of CD44 expression in subserous gallbladder carcinoma.
- To correlate CD44 expression levels with patient survival.
Main Methods:
- Studied 105 subserous gallbladder carcinoma samples and 33 non-tumoral gallbladders.
- Utilized streptavidin-biotin technique with anti-CD44 antibodies for staining.
- Followed 80 carcinoma patients for up to 105 months.
Main Results:
- CD44 expression was normal in 91% of controls but abnormal in 57% of cancer samples.
- 50% of cancers showed reduced CD44 expression, and 24% showed no expression.
- No significant survival differences were found for lower/absent CD44 expression, but higher expression correlated with early mortality.
Conclusions:
- Approximately 50% of subserous gallbladder carcinomas exhibit abnormal CD44 expression.
- Altered CD44 expression patterns are common in this cancer type.
- Further research may clarify CD44's prognostic value in gallbladder carcinoma.
